Where Sangamo Therapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 9 analysts have published their opinion on Sangamo Therapeutics (NASDAQ:SGMO) stock. The average price target for the stock is $5.22, a decrease of 38.08% from the previous average price target of $8.43. The majority of the analysts are bullish on the stock.
November 06, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have a bullish outlook on Sangamo Therapeutics, with an average price target of $5.22, down 38.08% from the previous target.
The average price target for Sangamo Therapeutics has decreased significantly, which may indicate a lower expected performance for the stock. However, the majority of analysts are still bullish on the stock, which could potentially offset the negative impact of the lower price target.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100